RxWIRE Newsletter
Home
»
Blog
Allegiant Rx Blog
03-23-2017
RxWIRE Newsletter – March 23, 2017
Acting on a request from three influential U.S. senators, the government’s accountability arm confirmed that it will investigate potential abuses of the Orphan Drug Act.
Read More
03-16-2017
RxWIRE Newsletter – March 16, 2017
In theory, citizen petitions about drug safety are supposed to be exactly what they sound like: a way for anyone to bring concerns straight to the Food and Drug Administration. In practice, many citizen petitions are filed by none other than pharmaceutical companies themselves—as a way of fighting off a...
Read More
03-09-2017
RxWIRE Newsletter – March 9, 2017
The Pharmacy Benefit Management Institute (PBMI) will award six organizations with their 2017 Excellence Award today at their 22nd Annual Drug Benefit Conference in Orlando, Florida. Each organization is recognized for exceptional programs and strategies contributing to cost containment, care management, and quality improvement for the drug benefit.
Read More
03-02-2017
RxWIRE Newsletter – March 2, 2017
As payers continue to foot the bill for orphan drugs, sales of these rare disease treatments are forecast to grow 11 percent over the next five years — to $209 billion. And this is more than twice the expected increase in sales of all other prescription medicines, according to a...
Read More
